Biotech: Page
-
PharmaVoice Team/PharmaVoice
Strategic Facility Planning
The biotech industry continues to create successful new companies through entrepreneurial ventures, university spin-offs, and other technology-transfer mechanisms. As these companies succeed and grow, facility and operational considerations become more important. Biotechnology executives find t...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
With more than 1,700 exhibitors, 60-plus Pavilions and Product Focus Zones, and more than 19,000 attendees from around the world, the annual BIO conference once again promises to be the premier global event for the biotechnology industry. Biotechnology represents big business in the United Stat...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Getty Images
TrendlineTech for Clinical Trials
Companies that utilize these emerging technologies wisely are likely to find an edge in the increasingly competitive drug development arena.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
An Agile Approach to Benefit Biotechnology Research
An Agile Approach to Benefit Biotechnology Research The biotechnology industry can take advantage of building upon the lessons learned by experienced contract research organizations that have performed clinical studies on behalf of pharmaceutical and medical-device sponsors. One of the best p...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cardiac Safety and Efficacy: An Open Discussion
On Aug. 11, 2006, 16 representatives from ECG core labs located around the world convened in Milwaukee, Wisc., for a one-day meeting with Dr. Norman Stockbridge, Head of the Cardio-Renal Board of the Food and Drug Administration. Topics covered ranged from recent developments instituted by the FD...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Biotech: The States of the Industry
Biotech: The States of the Industry To harness talent and leverage the niche characteristics to grow business, the biosciences require the specific capabilities certain regions have to offer. By Taren Grom VIEW on Biotechnogy April 2007 In this special Forum, Governors from five ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
April 15-19 Society for Biomolecular Sciences 13th Annual Conference & Exhibition Palais de Congres de Montreal, Montreal, Canada For more information, contact Marietta Manoni, Society for Biomolecular Sciences, at 203-743-1336, e-mail [email protected], or visit sbsonline.org. April 16-17 ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Evolving Role of the Clinical Project Manager
The Evolving Role of the Clinical Project Manager By Denise Myshko Forum Clinical studies have become more complicated. More studies are multinational, which means that projects must adhere to a variety of regulations and laws. Today’s studies also require project managers to work across teams to...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions Pharma POOL Mark Acosta Diana Bodden Anne Carlson Robert Corrie Cynthia Devereux Barry Gorewit Patrick Gose Darbi James Lawrence Kristoff Richard Laurie Randy Lawson Dr. David Levin Rita Myers June Nguyen Lynda Parker Bradley Pierson John Schillo ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
On the Calendar February 2007 Industry Events Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is dis...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Lou Barbato Tikvah Names VP, Clinical R&D, and Chief Medical Officer Atlanta-based Tikvah Therapeutics has named Lou Barbato, M.D., as VP, clinical research and development, and chief medical officer. Tikvah acquires, develops, and commercializes novel therapeutics related to ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Greg Sarian discusses executive trading rules. Contributed by Greg Sarian In an age when corporate scandals are top of mind and full financial disclosure is a must, executives may find it difficult to trade their company’s stock without raising eyebrows about how their insider knowledge may have ...
By Greg Sarian • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
PDUFA Update FDA Requests $87.4 million increase The FDA has put before Congress its recommendations for reauthorizing the Prescription Drug User Fee program (PDUFA). If adopted, PDUFA IV — the fourth reauthorization since the program began almost 15 years ago — would significantly broaden and up...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Medicare Part D: It’s Crunch Time … Again Manufacturers are facing déjà vu with Part D. While the 2006 Part D year recently came to a close and the 2007 Part D year is nascent, crucial decisions related to 2008 Part D are right around the corner. The Centers for Medicare and Medicaid Services (CM...
By Kevin Barnett • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Addressing the Silo Mentality
The industry is made up of hundreds of companies, public and private, large and small, some with highly developed R&D and commercial capabilities, and some with little more than two brilliant scientists and a molecule. cross-functional communications Anyone who works in the pharmaceutical and...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
January 16-17 Pharma Pricing Strategies Radisson SAS, Rome For more information, contact Martin Manik, Jacob Fleming Group, at 42-12-5825-2729, e-mail [email protected], or visit jacobfleming.com. January 16-18 Pharmaceutical Leaders’ Summit Delray Beach Marriott, Delray Beach, Fla. F...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies The breakthrough use of automated data mining and predictive analytics will ultimately make the costly, inefficient one-size-fits-all ‘shotgun’ mass-media marketing approach to consumers obsolete, says Michael D. Weintraub, Founder, Chairma...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Winds of Change Continue for the CME Community
medical education The updated criteria for CME means there will be an increased emphasis on measuring the outcomes of education. In recent years, the CME community has demonstrated the ability to manage complex change in the processes related to seeking funding, as well as assuring independence a...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
November 15 Turn Market Research into a Competitive Advantage McCann Erickson Building, New York For more information, contact Laura DeGroot, Healthcare Marketing & Communications Council, at 610-868-8299, e-mail [email protected], or visit hmc-council.org. November 15-16 International Pa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Marketplace
Featured Product and Service Showcases 21 West Partners AmerisourceBergen Specialty Group Avenue-e Health Strategies Compass Healthcare Communications ePharmaSolutions Inc. etrials Worldwide Inc. Medical Marketing Service Inc. Medidata Solutions Worldwide MedNet Solutions Inc. NXLevel...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor -- A Year in Preview
As another year comes to a close, it’s natural to stop and take stock of the events that have shaped the industry and to look ahead in anticipation of what’s next on the horizon. Once again, PharmaVOICE appreciates the time that so many industry executives took out of their busy schedules to comm...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Then & Now
Year in Preview Prognostications for the future PharmaVOICE asked several experts who participated in the December 2005 issue to review what they predicted for 2006. We wanted to know if indeed their prognostications for the future came true. In some cases, they were right on, and in other instan...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Year in Preview FAST FACTS The Industry at a Glance In 2007, the market will be absorbing changes that have defined a new economic reality, one in which growth is shifting from mature markets to emerging ones; new product adoption is not keeping pace with the loss of patent protection by establis...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Partnerships For Success
Year in Preview Strategic Alliances Strategic alliances — between pharmaceutical companies, contract research organizations, and other outsourcing providers — are expected to impact the future of drug development. Pharmaceutical companies are under pressure from the public, analysts, Wall Street,...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
GSW Launches Pink Tank Specialty marketing group offers expertise in understanding and speaking to women. Remarkably, many marketers don’t realize that women connect with brands differently from men. We established Pink Tank to help companies understand those differences and to counsel them on ho...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Industry Events October 2006 Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is distributed at more ...
By PharmaVoice Team • Jan. 2, 2008
Previous
